CS logo
small CS logo
Rocky Mountain Cancer Centers-Midtown

Denver, Colorado, United States
Cancer treatment center in Denver, Colorado
1800 N Williams St Suite 200, Denver, CO 80218

About Rocky Mountain Cancer Centers-Midtown


"Rocky Mountain Cancer Centers (RMCC) is Colorado's largest and most comprehensive provider of cancer care with over 50 physicians, in nearly 20 community-based locations across the state. Our history is rich in forward thinking and best practice development. We were formed in 1992 when a group of independent medical oncology practices joined together to become a network of community-based clinic sites. This practice model has stood the test of time and continues to have proven clinical and economic benefit for patients, employers and payers today."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
70
SWOG Cancer Research Network
31
Alliance for Clinical Trials in Oncology
23
ECOG-ACRIN Cancer Research Group
13
NRG Oncology
6
US Oncology Research
5
Amgen
3
Eisai Inc.
3
GOG Foundation
3
Eastern Cooperative Oncology Group
2
Favrille
2
Total Rows: 36

Clinical Trials at Rocky Mountain Cancer Centers-Midtown


During the past decade, Rocky Mountain Cancer Centers-Midtown conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 65 clinical trials were completed, i.e. on average, 67% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 41 clinical trials were completed. i.e. 164% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years77101021211616181816168811116644331010111114141313Started TrialsCompleted Trails201520162017201820192020202120220102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
2001-02-01
2005-01-01
Terminated
Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma
2000-11-01
Unknown status

Rows per page:

1–100 of 189

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Midtown" #1 sponsor was "National Cancer Institute (NCI)" with 70 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored and "NRG Oncology" with 13 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 36 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Midtown" #1 collaborator was "National Cancer Institute (NCI)" with 85 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 35 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 70National CancerInstitute (NCI): 70SWOG Cancer ResearchNetwork: 31SWOG Cancer ResearchNetwork: 31Alliance for ClinicalTrials in Oncology: 23Alliance for ClinicalTrials in Oncology: 23ECOG-ACRIN CancerResearch Group: 13ECOG-ACRIN CancerResearch Group: 13NRG Oncology: 6NRG Oncology: 6US Oncology Research: 5US Oncology Research: 5Amgen: 3Amgen: 3Eisai Inc.: 3Eisai Inc.: 3GOG Foundation: 3GOG Foundation: 3Eastern CooperativeOncology Group: 2Eastern CooperativeOncology Group: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 85National CancerInstitute (NCI): 85NRG Oncology: 13NRG Oncology: 13Canadian Cancer Trials Group: 7Canadian Cancer Trials Group: 7Eli Lilly and Company: 2Eli Lilly and Company: 2Genentech, Inc.: 2Genentech, Inc.: 2Prologue ResearchInternational: 2Prologue ResearchInternational: 2Agenus Inc.: 1Agenus Inc.: 1Austrian Breast &Colorectal Cancer StudyGroup (ABCSG): 1Austrian Breast &Colorectal Cancer StudyGroup (ABCSG): 1Bayer: 1Bayer: 1BeiGene: 1BeiGene: 1

Clinical Trials Conditions at Rocky Mountain Cancer Centers-Midtown


According to Clinical.Site data, the most researched conditions in "Rocky Mountain Cancer Centers-Midtown" are "Invasive Breast Carcinoma" (10 trials), "Breast Cancer" (9 trials), "Lymphoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Stage IV Lung Cancer AJCC v8" (9 trials). Many other conditions were trialed in "Rocky Mountain Cancer Centers-Midtown" in a lesser frequency.

Clinical Trials Intervention Types at Rocky Mountain Cancer Centers-Midtown


Most popular intervention types in "Rocky Mountain Cancer Centers-Midtown" are "Drug" (149 trials), "Other" (105 trials), "Biological" (77 trials), "Procedure" (45 trials) and "Radiation" (16 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (52 trials), "Quality-of-Life Assessment" (43 trials), "Questionnaire Administration" (24 trials), "Biospecimen Collection" (23 trials) and "Computed Tomography" (22 trials). Other intervention names were less common.

Clinical Trials Genders at Rocky Mountain Cancer Centers-Midtown


The vast majority of trials in "Rocky Mountain Cancer Centers-Midtown" are 152 trials for "All" genders, 32 trials for "Female" genders and 5 trials for "Male" genders.

Clinical Trials Status at Rocky Mountain Cancer Centers-Midtown


Currently, there are NaN active trials in "Rocky Mountain Cancer Centers-Midtown". undefined are not yet recruiting, 40 are recruiting, 79 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Rocky Mountain Cancer Centers-Midtown, 5 suspended trials, and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Rocky Mountain Cancer Centers-Midtown, 8 "Phase 1" clinical trials were conducted, 92 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 93Phase 3: 93Phase 2: 92Phase 2: 92Phase 1: 8Phase 1: 8Not Applicable: 4Not Applicable: 4Early Phase 1: 2Early Phase 1: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 79Active, not recruiting: 79Completed: 49Completed: 49Recruiting: 40Recruiting: 40Terminated: 12Terminated: 12Suspended: 5Suspended: 5Unknown status: 3Unknown status: 3Withdrawn: 1Withdrawn: 1